AJJ Medtech Holdings Limited and Hangzhou Huaxi Intelligent Technology Co., Ltd. have signed a Memorandum of Understanding (MOU) to jointly develop the world’s first multifunctional humanoid elderly care robot. This collaboration aims to address the growing demand for elderly care services, particularly in Singapore, where the population of seniors aged 65 and above is projected to reach 1.5 million by 2030.
The partnership will establish a joint venture in Singapore to develop and commercialise the robot, which will serve as a testbed for global expansion into markets such as Southeast Asia, Europe, and the United States. The robot will feature multi-language support, assisted living care, medical monitoring, and emotional interaction capabilities, making it suitable for various settings, including nursing homes and hospitals.
Huaxi Intelligent’s first-generation HT-XI humanoid robot has already secured over 1,000 pre-orders, indicating strong market interest. The collaboration aligns with Singapore’s healthcare strategy and global ageing trends, focusing on “Aging-in-Place” policies that promote community and home-based care solutions.
AJJ Medtech’s CEO, Zhao Xin, emphasised the potential for this collaboration to elevate the company’s technological and commercial standing in the Southeast Asian market. However, the project faces uncertainties, including regulatory approvals and market volatility, which may impact its timeline and success.
The companies plan to conduct clinical trials and pilot applications in Singapore’s nursing homes and medical institutions, with further announcements expected as the project progresses.
